Provexis (PXS)

 

PXS Share PerformanceMore

52 week high1.3499 28/11/16
52 week low0.3770 20/09/16
52 week change 0.0626 (16.05%)
4 week volume25,686,668 24/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Provexis sales surge by 148%

Provexis reported that total sales surged by 148% year-on-year to 228,000 in the year to 31 March 2017, up from 92,000 in 20...

Preliminary Results

RNS Number: 0460Q Provexis PLC 07 September 2017 7 September 2017 Provexis plc ("Provexis" or the "Company") PRELIMINARY RESULTS for the YEAR ended 31 MARCH 2017 Provexis plc ('Provexis' or the 'Company'), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, announces...

Holding(s) in Company

RNS Number: 6083M Provexis PLC 04 August 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Provexis plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposa...

Results of placing

RNS Number: 5434M Provexis PLC 31 July 2017 31 July 2017 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS I...

Funding Update

RNS Number: 4846M Provexis PLC 28 July 2017 28 July 2017 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS...

Funding Update

RNS Number: 8750J Provexis PLC 03 July 2017 3 July 2017 Provexis plc Funding update Provexis plc ('Provexis' or the 'Company'), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, is pleased to announce a funding update. First Subscription - completed in May 2017 The Company confirm...

Price Monitoring Extension

RNS Number: 7263H Provexis PLC 09 June 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A...

Second Price Monitoring Extn

RNS Number: 1891H Provexis PLC 05 June 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined percentage a...

Fundamental DataMore

EPS-0.02
Dividend yield0 %

Latest discussion posts More

  • Re: Blood pressure

    Yes, it is but it will make no difference as the message is not getting through to the vast majority of people many of whom have made unhealthy lifestyle choices. Many of these ...
    19-Sep-2017
    Colbaltblue
  • Re: Fruitflow plus orders

    My monthly totals. August 20 to September 20. 1833.
    19-Sep-2017
    Colbaltblue
  • Re: Blood pressure

    Good news! I note there is still no results from the resVida and Fruitflow-II study in the states???
    18-Sep-2017
    Junior30

Users' HoldingsMore

Users who hold Provexis also hold..
SCIENCE SPRT52%
GULF KEYSTONE18%
LLOYDS GRP.15%
SAREUM13%
RANGE RES.12%

Codes & Symbols

ISINGB00B0923P27
SymbolsPXS, LSE:PXS, PXS.L, PXS:LN, LON:PXS, XLON:PXS